11/14/2024
4:46 PM | Ascendis Pharma A/S (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
| Form SC 13G/A | |
11/14/2024
1:57 PM | Ascendis Pharma A/S (Subject)
JANUS HENDERSON GROUP PLC (Filed by)
| Form SC 13G/A | |
11/14/2024
8:31 AM | Ascendis Pharma A/S (Subject)
Avoro Capital Advisors LLC (Filed by)
| Form SC 13G/A | |
11/13/2024
3:02 PM | Ascendis Pharma A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/12/2024
8:51 AM | Artisan Partners Limited Partnership (Filed by)
Ascendis Pharma A/S (Subject)
| Form SC 13G/A | |
11/08/2024
9:34 AM | Ascendis Pharma A/S (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SC 13G/A | |
11/04/2024
6:05 AM | Ascendis Pharma A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
|
09/30/2024
7:35 AM | Ascendis Pharma A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/27/2024
3:59 PM | Ascendis Pharma A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/18/2024
4:20 PM | Ascendis Pharma A/S (Filer)
| Form 424B5 | |
09/18/2024
3:01 PM | Ascendis Pharma A/S (Filer)
| Form F-3ASR | |
09/16/2024
6:28 AM | Ascendis Pharma A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/16/2024
6:32 AM | Ascendis Pharma A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/11/2024
3:01 PM | Ascendis Pharma A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/03/2024
4:10 PM | Ascendis Pharma A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/03/2024
4:11 PM | Ascendis Pharma A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/03/2024
4:14 PM | Ascendis Pharma A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/12/2024
6:05 AM | Ascendis Pharma A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/28/2024
5:07 AM | Ascendis Pharma A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/31/2024
3:26 PM | Ascendis Pharma A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/29/2024
3:08 PM | Ascendis Pharma A/S (Filer)
| Form SD
Specialized Disclosure Report | |
05/14/2024
1:37 PM | Ascendis Pharma A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/24/2024
8:16 AM | Ascendis Pharma A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/07/2024
10:31 AM | Ascendis Pharma A/S (Subject)
Bodenhoff Mads (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/05/2024
8:39 PM | Ascendis Pharma A/S (Subject)
Fairey William (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/05/2024
8:47 AM | Ascendis Pharma A/S (Subject)
Cha Albert (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/05/2024
7:04 AM | Ascendis Pharma A/S (Subject)
SPROGOE KENNETT (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/05/2024
7:14 AM | Ascendis Pharma A/S (Subject)
Morrison Lisa (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/05/2024
6:52 AM | Ascendis Pharma A/S (Subject)
MIKKELSEN JAN MOLLER (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/05/2024
6:37 AM | Ascendis Pharma A/S (Subject)
JENSEN FLEMMING STEEN (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/04/2024
1:54 PM | Ascendis Pharma A/S (Subject)
PEDERSEN ANNI LOTTE KIRSTINE SONDERBJERG (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/04/2024
2:07 PM | Ascendis Pharma A/S (Subject)
JENSEN MICHAEL WOLFF (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/04/2024
2:17 PM | Ascendis Pharma A/S (Subject)
RASMUSSEN PETER (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/04/2024
1:36 PM | Ascendis Pharma A/S (Subject)
SMITH SCOTT THOMAS (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/04/2024
1:24 PM | Ascendis Pharma A/S (Subject)
SINGEL STINA (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/01/2024
10:00 AM | Ascendis Pharma A/S (Subject)
HOLTUG LARS (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/29/2024
4:13 PM | Ascendis Pharma A/S (Subject)
Morrison Lisa (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/29/2024
3:21 PM | Ascendis Pharma A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/28/2024
5:17 PM | Ascendis Pharma A/S (Subject)
MIKKELSEN JAN MOLLER (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/27/2024
4:45 PM | Ascendis Pharma A/S (Subject)
PEDERSEN ANNI LOTTE KIRSTINE SONDERBJERG (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/21/2024
2:17 PM | Ascendis Pharma A/S (Subject)
JENSEN MICHAEL WOLFF (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
A “Thank You Gift” From Pres. Trump - Genius (Ad) The "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you.
A tax-free gift so powerful it could reshape the financial destinies of millions of IRA and 401(k) owners… Claim your FREE 2024 Gold Guide |
02/16/2024
4:14 PM | Ascendis Pharma A/S (Subject)
Volck Birgitte (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/16/2024
4:15 PM | Ascendis Pharma A/S (Subject)
JENSEN FLEMMING STEEN (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/16/2024
4:16 PM | Ascendis Pharma A/S (Subject)
SMITH SCOTT THOMAS (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/14/2024
10:40 AM | Ascendis Pharma A/S (Subject)
JENSEN MICHAEL WOLFF (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/14/2024
8:17 AM | Ascendis Pharma A/S (Subject)
Avoro Capital Advisors LLC (Filed by)
| Form SC 13G/A | |
02/13/2024
10:57 AM | Ascendis Pharma A/S (Subject)
JANUS HENDERSON GROUP PLC (Filed by)
| Form SC 13G/A | |
02/12/2024
5:12 AM | Artisan Partners Limited Partnership (Filed by)
Ascendis Pharma A/S (Subject)
| Form SC 13G/A | |
02/09/2024
1:17 PM | Ascendis Pharma A/S (Subject)
MIKKELSEN JAN MOLLER (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/09/2024
7:35 AM | Ascendis Pharma A/S (Subject)
FMR LLC (Filed by)
| Form SC 13G/A | |
02/07/2024
3:15 PM | Ascendis Pharma A/S (Filer)
| Form 20-F
Registration statement / Annual report / Transition report | |
02/02/2024
12:18 PM | Ascendis Pharma A/S (Subject)
WESTFIELD CAPITAL MANAGEMENT CO LP (Filed by)
| Form SC 13G/A | |
01/29/2024
7:36 AM | Ascendis Pharma A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/08/2024
5:05 AM | Ascendis Pharma A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/08/2024
5:08 AM | Ascendis Pharma A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/02/2024
5:08 AM | Ascendis Pharma A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/20/2023
7:30 AM | Ascendis Pharma A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/11/2023
7:32 AM | Ascendis Pharma A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/07/2023
1:53 PM | Ascendis Pharma A/S (Subject)
Volck Birgitte (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/05/2023
3:20 PM | Ascendis Pharma A/S (Subject)
RASMUSSEN PETER (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/29/2023
5:04 AM | Ascendis Pharma A/S (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
Free ASND Stock Alerts